From equipment upgrades to new construction and expansion: the structural upheaval in US industrial capital expenditure

The Inflection Point Behind the Data

Industrial SalesLeads data shows that in February 2026, 133 new capital projects were added in the U.S. industrial manufacturing sector, a 5% decrease from 140 in January. On the surface, the market appears to be cooling, but structurally, it is sending a stronger signal: renovation and equipment upgrade projects fell 18% from January, while the number of new construction and expansion projects remained steady. This means that more and more manufacturers are no longer satisfied with partial optimization of existing facilities, but are choosing to build entirely new capacity from scratch—a typical characteristic of a cyclical inflection point.

Looking at a longer cycle, U.S. manufacturing is undergoing a replacement cycle centered on "discarding the old and building the new." Old facilities are being phased out due to outdated technology or inefficient supply chains, while new factories tend to locate closer to end markets or policy-guided industrial belts. The 13 factory closure projects tracked in February precisely confirm that the clearing of inefficient capacity is accelerating.

Major Projects Driving: Capital Concentrating on Strategic Areas

The most notable signal in February came from project scale. That month, 19 industrial projects with an estimated value exceeding $100 million entered planning, including Eli Lilly's proposed $4 billion investment in a 925,000-square-foot processing campus in Fogelsville, Pennsylvania, a project that directly set a new record for regional pharmaceutical investment.

Large-scale projects are becoming the mainstay of U.S. manufacturing investment. In addition to Eli Lilly, major investments have landed in pharmaceuticals, steel, aerospace, energy equipment, defense shipbuilding, and other fields. For example, a pharmaceutical project in Lower Gwynedd, Pennsylvania, involves a $1 billion investment; a steel mill expansion and equipment upgrade in Gary, Indiana, is investing $900 million; an aerospace components factory in Hurt, Virginia, is investing $500 million; and an energy infrastructure equipment expansion project in North Carolina has a total investment of $421 million.

What do these projects have in common? They almost all point to two keywords: "supply chain security" and "advanced manufacturing." Pharmaceutical companies are accelerating reshoring to reduce dependence on active pharmaceutical ingredients; energy equipment manufacturers are responding to the needs of grid modernization and new energy integration; defense shipyards are expanding capacity driven by geopolitical tensions. The role of policy cannot be ignored—whether it is the Inflation Reduction Act's incentives for clean energy or the CHIPS Act's tilt toward high-end manufacturing, both are reshaping companies' long-term investment decisions.

Regional Landscape Reshaped: Who is Rising?

Looking at the distribution of projects, New York State leads with 10 projects, followed closely by Massachusetts with 9, while North Carolina, Texas, Tennessee, and other states are all active. But what truly deserves attention is Pennsylvania, which, thanks to the Eli Lilly and Lower Gwynedd projects, has become the absolute winner in terms of investment amount. Indiana, relying on its traditional manufacturing base in steel and pharmaceuticals, is showing potential for upgrades.This regional divergence is no accident. The Northeast Corridor (New York-Pennsylvania-Massachusetts) is leveraging life sciences, pharmaceuticals, and research resources to become a hub for high-value-added manufacturing; the Southeast (North Carolina, Georgia, Florida), relying on population inflows and logistics convenience, is expanding rapidly in energy equipment, defense shipbuilding, fiber-optic cables, and other fields; the Midwest (Indiana, Wisconsin, Iowa) maintains its traditional heavy industry advantages while upgrading toward electric tools, agricultural product processing, and other directions.

Texas still cannot be ignored—although only 8 projects were recorded in February, its projects are usually larger in scale. More importantly, Texas's existing advantages in energy, aerospace, and semiconductors allow it to continue serving as the ballast of U.S. manufacturing.

Industry Temperature: Which Sectors Are Heating Up, and Which Are Cooling Down?

The fastest-warming sectors are concentrated in three categories: first, life sciences/pharmaceuticals—Eli Lilly and other companies continue to ramp up their investments, and a pharmaceutical project in North Chicago, Illinois, also plans to invest $380 million to build two plants; second, energy infrastructure equipment—projects in North Carolina and Mississippi directly echo the grid investment cycle; third, defense and aviation—aerospace components in Virginia and defense shipyards in Florida both confirm the security logic.

The relatively lukewarm sectors are traditional consumer goods manufacturing, such as electric tools and textiles. However, even in these sectors, companies are optimizing capacity through new construction or relocation. For example, an electric tool manufacturer in Menomonee Falls, Wisconsin, plans to invest $206 million to build a 750,000-square-foot manufacturing and warehouse facility, while renovating a 164,000-square-foot R&D laboratory—indicating that the integration of "R&D + manufacturing" is becoming a new trend.

Under pressure are traditional manufacturers that have long relied on aging plants and lack the capability for technological upgrading. The 13 factory closure projects in February were mostly concentrated in the old industrial areas of the Midwest. These companies are facing the dual squeeze of high equipment upgrade costs and competition from new capacity, and may continue to contract in the coming years.

Key Observations

1. Investment paradigm shift: Equipment upgrade projects plummeted 18%, while new construction and expansion projects remained stable, meaning U.S. industrial investment is shifting from "patching up existing capacity" to "competing for new capacity." 2. Concentrated surge of mega-projects: 19 projects exceeding $100 million set a recent high, with capital clearly concentrating toward strategically significant sectors. 3. Life sciences become a new growth pole: Eli Lilly's $4 billion investment makes the pharmaceutical industry the biggest beneficiary of this round of reindustrialization. 4. Regional competition enters a new stage: Pennsylvania, North Carolina, and Indiana, leveraging policy resources and locational advantages, are challenging the standing of traditional industrial powerhouses. 5. Closures and new construction coexist: 13 factory closure projects and 32 new construction projects occurring in the same period reveal that manufacturing is undergoing intense "creative destruction."

U.S. Industrial Trends OutlookOver the next 3–5 years, U.S. manufacturing will evolve along three main tracks: first, megaprojects will continue to dominate capital expenditure, especially in high-barrier sectors such as pharmaceuticals, energy equipment, and defense; second, the regional landscape will see growth across multiple hubs rather than dominance by a single state, with the Southeast and the Northeast Corridor steadily increasing their shares; third, the equipment upgrade cycle will take on a "wave-like" pattern—once newly built capacity enters its operational phase, demand for retrofitting existing facilities will rise again.

For investors and corporate decision-makers, the current data signals mean that tracking the locations of major projects and the upstream and downstream of the industrial chain is more valuable than focusing on the monthly aggregate number of projects. The "new-build era" of American manufacturing has arrived—and this is not a short-lived rebound, but a structural restructuring that will last for many years.